MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,956 Approvals
Showing 1341 to 1360 of 1,956 approvalsPage 68 of 98

Esmya

Authorisation: Feb 22, 2012

Zelboraf

Authorisation: Feb 17, 2012

Caprelsa

Authorisation: Feb 16, 2012

Colobreathe

Authorisation: Feb 13, 2012

Desloratadine ratiopharm

Authorisation: Jan 13, 2012

Efavirenz Teva

Authorisation: Jan 9, 2012

Repaglinide Accord

Authorisation: Dec 22, 2011

Ameluz

Authorisation: Dec 13, 2011

Edarbi

Authorisation: Dec 7, 2011

Dificlir

Authorisation: Dec 5, 2011

Dasselta

Authorisation: Nov 28, 2011

Edurant

Authorisation: Nov 28, 2011

Desloratadine Teva

Authorisation: Nov 24, 2011

Komboglyze

Authorisation: Nov 24, 2011

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.